ConductScience.org, home

Paper10949029

Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice.

Shimomura I and 5 others. Mol Cell, 2000. Cited by 632 papers, by iCite.

Cite this record

ConductScience Library. Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice. Papers, record 10949029. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/10949029

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Decreased IRS-2 and increased SREBP-1c lead to mixed insulin resistance and sensitivity in livers of lipodystrophic and ob/ob mice.
PubMed
Journal
Mol Cell
PubMed
Year
2000
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.
PubMed
Citations, by iCite
632
iCite
Relative citation ratio, by iCite
12.9
iCite
Revised in PubMed
2020-01-11
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Shimomura II
2Matsuda MM
3Hammer RER E
4Bashmakov YY
5Brown MSM S
6Goldstein JLJ L

Source PubMed

Download CSV of authors

Topics29

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
CCAAT-Enhancer-Binding ProteinsMajor topic
DNA-Binding ProteinsMajor topic
Insulin ResistanceMajor topic
LipodystrophyMajor topic
LiverMajor topic
Nuclear ProteinsMajor topic
ObesityMajor topic
PhosphoproteinsMajor topic
Transcription FactorsMajor topic
Animals
Base Sequence
DNA Primers
Gene Expression
Glucagon
Humans
In Vitro Techniques
Insulin
Insulin Receptor Substrate Proteins
Intracellular Signaling Peptides and Proteins
Male
Mice
Mice, Inbred C57BL
Mice, Obese
Mice, Transgenic
Models, Biological
RNA, Messenger
Rats
Rats, Sprague-Dawley
Sterol Regulatory Element Binding Protein 1

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
HL-20948NHLBI NIH HHSUnited StatesP01HL020948PubMed and NIH

Source NIH RePORTER

Download CSV of grants

Cited by312

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 632 citations.

PMIDTitleJournalYearIn PapersSource
42820929Helios is critical for Treg effector differentiation in adipose autoimmunity.J Exp Med2026https://conductscience.org/library/papers/42820929PubMed
42509792FGF21 and SHBG as Putative Hepatic Axes in Maternal Metabolic Adaptation: A Hypothetical Framework for Postpartum Insulin Sensitivity Restoration.Biomolecules2026https://conductscience.org/library/papers/42509792PubMed
42241511Triglyceride-Rich Lipoprotein Metabolism and Cardiovascular Risk in Diabetes: Bedside to Bench to Bedside.Circ Res2026https://conductscience.org/library/papers/42241511PubMed
42215843Metabolic dysfunction-associated steatotic liver disease: pathogenesis and novel treatment options.Mol Biomed2026https://conductscience.org/library/papers/42215843PubMed
42158822Insulin increases expression of cannabinoid receptor 1 by suppressing lysosomal degradation via ERK signaling pathway.Int J Med Sci2026https://conductscience.org/library/papers/42158822PubMed
42063103
Recapitulation of clinical and molecular hallmarks of lipid-induced hepatic insulin resistance in a zonated, vascularized human liver acinus microphysiological system during metabolic dysfunction-associated steatotic liver disease (MASLD) progression.
BMC Biotechnol2026https://conductscience.org/library/papers/42063103PubMed
41926189The ULK1-NCOA3 axis restrains de novo lipogenesis and prevents diet-induced steatohepatitis and fibrosis in mice.J Clin Invest2026https://conductscience.org/library/papers/41926189PubMed
41276502Fructose and follistatin potentiate acute MASLD during complete hepatic insulin resistance.Nat Commun2025https://conductscience.org/library/papers/41276502PubMed
41196673Molecular mechanisms of metabolic dysfunction-associated steatotic liver disease (MASLD): functional analysis of glucose and fructose metabolism pathways.Clin Sci (Lond)2025https://conductscience.org/library/papers/41196673PubMed
41010498Effects of Diet and Exercise on Mitochondrial Health in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Role of Ceramides.Nutrients2025https://conductscience.org/library/papers/41010498PubMed
41004573Targeted inhibition of hepatic de novo ceramide synthesis ameliorates MASH.Sci Adv2025https://conductscience.org/library/papers/41004573PubMed
40943477Treatment of Dyslipidemia in Patients with Type 1 Diabetes Mellitus: A Review of Current Evidence and Knowledge Gaps.Int J Mol Sci2025https://conductscience.org/library/papers/40943477PubMed
40868889Immune Dysregulation Connecting Type 2 Diabetes and Cardiovascular Complications.Life (Basel)2025https://conductscience.org/library/papers/40868889PubMed
40521082Hepatic Lipidomics Unravels the Lipid-Lowering and Anti-Obesity Efficacy of Diacylglycerol Oil: Mechanistic Insights From High-Fat Diet-Induced Obese Mice.Food Sci Nutr2025https://conductscience.org/library/papers/40521082PubMed
40444167Biochemical, histological, and immunohistochemical study on the therapeutic effects and mechanism of coenzyme Q10 in type 2 diabetes mellitus.Res Pharm Sci2025https://conductscience.org/library/papers/40444167PubMed
40247011Insulin resistance in type 2 diabetes mellitus.Nat Rev Endocrinol2025https://conductscience.org/library/papers/40247011PubMed
40227546Understanding the Link Between Sterol Regulatory Element Binding Protein (SREBPs) and Metabolic Dysfunction Associated Steatotic Liver Disease (MASLD).Curr Obes Rep2025https://conductscience.org/library/papers/40227546PubMed
40201816Canine obesity, overweight, and adipokine serum concentration are associated with hematological, biochemical, hormonal, and cardiovascular markers.Open Vet J2025https://conductscience.org/library/papers/40201816PubMed
39524330High-fat-diet-induced hepatic insulin resistance per se attenuates murine de novo lipogenesis.iScience2024https://conductscience.org/library/papers/39524330PubMed
39287864Nonalcoholic Fatty Liver Disease and Staging of Hepatic Fibrosis.Adv Exp Med Biol2024https://conductscience.org/library/papers/39287864PubMed

See all 312 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
IRS13667PubTator's text mininghttps://conductscience.org/library/genes/3667NCBI Gene
IRS28660PubTator's text mininghttps://conductscience.org/library/genes/8660NCBI Gene
SREBF16720PubTator's text mininghttps://conductscience.org/library/genes/6720NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/10949029

GET https://conductscience.org/api/papers/v1/10949029/cited_by?page=2